Product Description
Repaglinide is a rapid-acting oral hypoglycemic agent. It stimulates pancreatic insulin secretion quickly, effectively lowering postprandial blood glucose. It acts fast and has a short duration, matching meal time flexibly and reducing the risk of prolonged hypoglycemia.
Indications
Improvement of glycemic control in adults with type 2 diabetes mellitus, alone or combined with other antidiabetic agents.
Directions for Use
Oral administration, take 15 minutes before meals.
Swallow whole with water.
Dose should be individualized according to blood glucose response under medical supervision.
Do not take if skipping a meal.
Product Features
- Fast onset, short action time
- Controls post-meal blood sugar effectively
- Flexible dosing with meals
- Low risk of delayed hypoglycemia
- Suitable for irregular meal schedules
Storage
Store sealed in a cool dry place, protect from light and moisture.
Warnings
- Contraindicated in type 1 diabetes, diabetic ketoacidosis and hypersensitivity.
- Risk of hypoglycemia; avoid skipping meals after taking.
- Use cautiously in liver and renal impairment patients.
- Not recommended for pregnant and breastfeeding women.
- Keep out of reach of children.
